Selected research
Market Structure
Global Transcatheter Heart Valve Therapies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Transcatheter Heart Valve Therapies market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Transcatheter Heart Valve Therapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Transcatheter Heart Valve Therapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Transcatheter Heart Valve Therapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Transcatheter Heart Valve Therapies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Transcatheter Heart Valve Therapies include Cardiac Dimensions, Mitralign, NeoChord, Edwards Lifesciences, Hanyu Medical, Abbott and Valgen Medtech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Transcatheter Heart Valve Therapies market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Transcatheter Heart Valve Therapies and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Transcatheter Heart Valve Therapies sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transcatheter Heart Valve Therapies market size, projected growth trends, production technologies, key applications, and end-use industries.
Transcatheter Heart Valve Therapies Segment by Company
Cardiac Dimensions
Mitralign
NeoChord
Edwards Lifesciences
Hanyu Medical
Abbott
Valgen Medtech
Transcatheter Heart Valve Therapies Segment by Type
Replacement Interventional Devices
Restorative Interventional Devices
Transcatheter Heart Valve Therapies Segment by Application
Hospital
Clinic
Transcatheter Heart Valve Therapies Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcatheter Heart Valve Therapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transcatheter Heart Valve Therapies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcatheter Heart Valve Therapies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Transcatheter Heart Valve Therapies market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcatheter Heart Valve Therapies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transcatheter Heart Valve Therapies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Transcatheter Heart Valve Therapies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Replacement Interventional Devices
- Restorative Interventional Devices
Applications
- Hospital
- Clinic
Companies covered
- Cardiac Dimensions
- Mitralign
- NeoChord
- Edwards Lifesciences
- Hanyu Medical
- Abbott
- Valgen Medtech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Transcatheter Heart Valve Therapies Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Transcatheter Heart Valve Therapies Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Transcatheter Heart Valve Therapies Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Transcatheter Heart Valve Therapies Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Transcatheter Heart Valve Therapies Market Dynamics
- 2.1 Transcatheter Heart Valve Therapies Industry Trends
- 2.2 Transcatheter Heart Valve Therapies Industry Drivers
- 2.3 Transcatheter Heart Valve Therapies Industry Opportunities and Challenges
- 2.4 Transcatheter Heart Valve Therapies Industry Restraints
3 Transcatheter Heart Valve Therapies Market by Manufacturers
- 3.1 Global Transcatheter Heart Valve Therapies Revenue by Manufacturers (2021-2026)
- 3.2 Global Transcatheter Heart Valve Therapies Sales by Manufacturers (2021-2026)
- 3.3 Global Transcatheter Heart Valve Therapies Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Transcatheter Heart Valve Therapies Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Transcatheter Heart Valve Therapies Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Transcatheter Heart Valve Therapies Manufacturers, Product Type & Application
- 3.7 Global Transcatheter Heart Valve Therapies Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Transcatheter Heart Valve Therapies Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Transcatheter Heart Valve Therapies Players Market Share by Revenue in 2025
- 3.8.3 2025 Transcatheter Heart Valve Therapies Tier 1, Tier 2, and Tier 3
4 Transcatheter Heart Valve Therapies Market by Type
- 4.1 Transcatheter Heart Valve Therapies Type Introduction
- 4.1.1 Replacement Interventional Devices
- 4.1.2 Restorative Interventional Devices
- 4.2 Global Transcatheter Heart Valve Therapies Sales by Type
- 4.2.1 Global Transcatheter Heart Valve Therapies Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Transcatheter Heart Valve Therapies Sales by Type (2021-2032)
- 4.2.3 Global Transcatheter Heart Valve Therapies Sales Market Share by Type (2021-2032)
- 4.3 Global Transcatheter Heart Valve Therapies Revenue by Type
- 4.3.1 Global Transcatheter Heart Valve Therapies Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Transcatheter Heart Valve Therapies Revenue by Type (2021-2032)
- 4.3.3 Global Transcatheter Heart Valve Therapies Revenue Market Share by Type (2021-2032)
5 Transcatheter Heart Valve Therapies Market by Application
- 5.1 Transcatheter Heart Valve Therapies Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.2 Global Transcatheter Heart Valve Therapies Sales by Application
- 5.2.1 Global Transcatheter Heart Valve Therapies Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Transcatheter Heart Valve Therapies Sales by Application (2021-2032)
- 5.2.3 Global Transcatheter Heart Valve Therapies Sales Market Share by Application (2021-2032)
- 5.3 Global Transcatheter Heart Valve Therapies Revenue by Application
- 5.3.1 Global Transcatheter Heart Valve Therapies Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Transcatheter Heart Valve Therapies Revenue by Application (2021-2032)
- 5.3.3 Global Transcatheter Heart Valve Therapies Revenue Market Share by Application (2021-2032)
6 Global Transcatheter Heart Valve Therapies Sales by Region
- 6.1 Global Transcatheter Heart Valve Therapies Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Transcatheter Heart Valve Therapies Sales by Region (2021-2032)
- 6.2.1 Global Transcatheter Heart Valve Therapies Sales by Region (2021-2026)
- 6.2.2 Global Transcatheter Heart Valve Therapies Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Transcatheter Heart Valve Therapies Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Transcatheter Heart Valve Therapies Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Transcatheter Heart Valve Therapies Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Transcatheter Heart Valve Therapies Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Transcatheter Heart Valve Therapies Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Transcatheter Heart Valve Therapies Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Transcatheter Heart Valve Therapies Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Transcatheter Heart Valve Therapies Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Transcatheter Heart Valve Therapies Revenue by Region
- 7.1 Global Transcatheter Heart Valve Therapies Revenue by Region
- 7.1.1 Global Transcatheter Heart Valve Therapies Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Transcatheter Heart Valve Therapies Revenue by Region (2021-2026)
- 7.1.3 Global Transcatheter Heart Valve Therapies Revenue by Region (2027-2032)
- 7.1.4 Global Transcatheter Heart Valve Therapies Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Transcatheter Heart Valve Therapies Revenue (2021-2032)
- 7.2.2 North America Transcatheter Heart Valve Therapies Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Transcatheter Heart Valve Therapies Revenue (2021-2032)
- 7.3.2 Europe Transcatheter Heart Valve Therapies Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Transcatheter Heart Valve Therapies Revenue (2021-2032)
- 7.4.2 Asia-Pacific Transcatheter Heart Valve Therapies Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Transcatheter Heart Valve Therapies Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Transcatheter Heart Valve Therapies Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Cardiac Dimensions
- 8.1.1 Cardiac Dimensions Company Information
- 8.1.2 Cardiac Dimensions Business Overview
- 8.1.3 Cardiac Dimensions Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Cardiac Dimensions Transcatheter Heart Valve Therapies Product Portfolio
- 8.1.5 Cardiac Dimensions Recent Developments
- 8.2 Mitralign
- 8.2.1 Mitralign Company Information
- 8.2.2 Mitralign Business Overview
- 8.2.3 Mitralign Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Mitralign Transcatheter Heart Valve Therapies Product Portfolio
- 8.2.5 Mitralign Recent Developments
- 8.3 NeoChord
- 8.3.1 NeoChord Company Information
- 8.3.2 NeoChord Business Overview
- 8.3.3 NeoChord Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 NeoChord Transcatheter Heart Valve Therapies Product Portfolio
- 8.3.5 NeoChord Recent Developments
- 8.4 Edwards Lifesciences
- 8.4.1 Edwards Lifesciences Company Information
- 8.4.2 Edwards Lifesciences Business Overview
- 8.4.3 Edwards Lifesciences Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Edwards Lifesciences Transcatheter Heart Valve Therapies Product Portfolio
- 8.4.5 Edwards Lifesciences Recent Developments
- 8.5 Hanyu Medical
- 8.5.1 Hanyu Medical Company Information
- 8.5.2 Hanyu Medical Business Overview
- 8.5.3 Hanyu Medical Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hanyu Medical Transcatheter Heart Valve Therapies Product Portfolio
- 8.5.5 Hanyu Medical Recent Developments
- 8.6 Abbott
- 8.6.1 Abbott Company Information
- 8.6.2 Abbott Business Overview
- 8.6.3 Abbott Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Abbott Transcatheter Heart Valve Therapies Product Portfolio
- 8.6.5 Abbott Recent Developments
- 8.7 Valgen Medtech
- 8.7.1 Valgen Medtech Company Information
- 8.7.2 Valgen Medtech Business Overview
- 8.7.3 Valgen Medtech Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Valgen Medtech Transcatheter Heart Valve Therapies Product Portfolio
- 8.7.5 Valgen Medtech Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Transcatheter Heart Valve Therapies Value Chain Analysis
- 9.1.1 Transcatheter Heart Valve Therapies Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Transcatheter Heart Valve Therapies Production Mode & Process
- 9.2 Transcatheter Heart Valve Therapies Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Transcatheter Heart Valve Therapies Distributors
- 9.2.3 Transcatheter Heart Valve Therapies Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst